Brief: Ventyx Biosciences Q2 EPS USD -0.38 Vs. IBES Estimate USD -0.47
07/08/2025 21:05
Aug 07 (Reuters) - Ventyx Biosciences Q2 net income USD -26.987 million vs. IBES estimate USD -32.5 million. Q2 operating expenses USD 29.333 million
Recent news on Ventyx Biosciences
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (updated)
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
Deals of the day-Mergers and acquisitions